UNIGE document Scientific Article
previous document  unige:77514  next document
add to browser collection

Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma

Published in World journal of gastroenterology. 2013, vol. 19, no. 3, p. 328-330
Abstract The assessment of the prognosis in patients with early hepatocellular carcinoma represents a hot-topic issue that requires further improvements and clarifications. The life expectancy of the patients has been shown to depend on several clinical and histological parameters (such as patient's general conditions, macroscopic tumor morphology and histopathology). Recently, the prognostic role of some biomarkers [i.e., alpha-fetoprotein (AFP)] has been also investigated with controversial findings mainly on the assessment of patient survival. The study by Giannini et al failed to show a prognostic value of AFP on survival of patients with well-compensated cirrhosis and small hepatocellular carcinoma. Since the study presents some limitations, a larger clinical trial is needed to clarify the potential prognostic role of serum AFP levels in these patients.
Keywords Carcinoma, Hepatocellular/blood/diagnosis/mortalityHumansLiver Neoplasms/blood/diagnosis/mortalityPrognosisSensitivity and SpecificitySurvival RateTumor Markers, Biological/bloodAlpha-Fetoproteins/metabolism
PMID: 23372353
Full text
Article (Published version) (523 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups L'athérosclérose et ses complications cliniques (591)
Ophtalmologie expérimentale (925)
(ISO format)
ASRIH, Mohamed et al. Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma. In: World journal of gastroenterology, 2013, vol. 19, n° 3, p. 328-330. doi: 10.3748/wjg.v19.i3.328 https://archive-ouverte.unige.ch/unige:77514

442 hits

0 download


Deposited on : 2015-11-23

Export document
Format :
Citation style :